Abstract: This disclosure relates to a method for determining a component behavior of at least one vehicle component of a motor vehicle. A start-up of the at least one vehicle component of the motor vehicle for the first time is registered. Thereafter, a component identifier is created, which is assigned to the registered vehicle component. The component identifier includes a sequence of a predetermined number of characters, each character being generated by a random generator. Furthermore, operating data of the vehicle component in question are collected, which are assigned to the component identifier assigned to the vehicle component in question. The component behavior of the vehicle component in question is determined on the basis of the operating data assigned to the component identifier in question. This disclosure further relates to the vehicle component and to a motor vehicle having one or more vehicle components of this type.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method of diagnosis of primary headache. More particular, the invention relates to a method of differentiating between primary and secondary headache in a human subject by applying a biomarker for primary headache. In a particular aspect, the invention relates to a method for the diagnosis of migraine. In one particular aspect the invention relates to the field of theranostic and personalized medicine.

Abstract: The present invention relates to dosage units of oral films for the administration of active pharmaceutical ingredients (API), such as analgesics, relaxants, anxiolytics, sedatives, hypnotics, narcotics, anesthetics and/or other API with peripheral and/or central nervous effects, in particular for use in the treatment of pain, metabolic disorders and diseases of the central nervous system (CNS). More particular the invention relates to dosage units of oral films comprising relaxants, anxiolytics, sedatives, hypnotics, narcotics, anesthetics and/or analgesics prone to misuse and abuse, such as overdosing. More particular, the invention relates to dosage units of oral films comprising propofol. In a further aspect, the invention relates to dosage units of oral films comprising propofol for use in the treatment of a subject suffering from migraine.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for producing a dairy product using an enzyme having lactase activity.

Abstract: The present invention relates to a method for extracting components from yeast cells with a purified phospholipase.

Abstract: The present invention relates to an enzymatic process for making a milk-based protein hydrolysate and use of such hydrolysate, e.g., in an infant formula composition.

Abstract: The present invention relates to a method of selecting a protein variant having modified immunogenicity as compared to the parent protein comprising the steps obtaining antibody binding peptide sequences, using the sequences to localise epitope sequences on the 3-dimensional structure of parent protein, defining an epitope area including amino acids situated within 5 ? from the epitope amino acids constituting the epitope sequence, changing one or more of the amino acids defining the epitope area of the parent protein by genetical engineering mutations of a DNA sequence encoding the parent protein, introducing the mutated DNA sequence into a suitable host, culturing said host and expressing the protein variant, and evaluating the immunogenicity of the protein variant using the parent protein as reference. The invention further relates to the protein variant and use thereof, as well as to a method for producing said protein variant.

Abstract: The present invention relates to a process for production of cooked vegetable food materials having reduced levels of acrylamide.

Abstract: The present invention relates to a method of selecting a protein variant having modified immunogenicity as compared to the parent protein comprising the steps obtaining antibody binding peptide sequences, using the sequences to localise epitope sequences on the 3-dimensional structure of parent protein, defining an epitope area including amino acids situated within 5 ? from the epitope amino acids constituting the epitope sequence, changing one or more of the amino acids defining the epitope area of the parent protein by genetical engineering mutations of a DNA sequence encoding the parent protein, introducing the mutated DNA sequence into a suitable host, culturing said host and expressing the protein variant, and evaluating the immunogenicity of the protein variant using the parent protein as reference. The invention further relates to the protein variant and use thereof, as well as to a method for producing said protein variant.

Abstract: The present invention relates to a method for producing an acidified milk drink using an enzyme having transglutaminase activity.

Abstract: The invention relates to a process for producing a triglyceride product comprising the steps of: (a) subjecting a triglyceride feedstock comprising at least 25 mole %, based on the total amount of acyl groups in the triglycerides, unsaturated C18 fatty acid residues to an alcoholy- sis reaction with an alcohol having 1 to 6 carbon atoms (C1-C6) to obtain a reaction mixture, 5 wherein the conversion is at least 65%; (b) separating from the reaction mixture produced in step (a) fractions comprising (i) unsaturated C18 fatty acid alkyl esters and (ii) glycerides; and (c) using the fractions (i) and (ii) or subfractions thereof in a condensation reaction catalyzed by a lipase to produce a triglyceride product comprising at least 80 mole % unsaturated fatty acids.

Abstract: The present invention relates to stabilization of asparaginase enzymes.